404 studies found for:
"Anemia, Hemolytic, Congenital"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
|
||||
| 2 | Active, not recruiting |
Unrelated Donor BMT for Treatment of Patients With PGK Deficiency
|
||||
| 3 | Terminated |
The Dallas Hereditary Spherocytosis Cohort Study
|
||||
| 4 | Completed |
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
|
||||
| 5 | Completed |
Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
|
||||
| 6 | Recruiting |
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
|
||||
| 7 |
Completed
Has Results |
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
|
||||
| 8 | Completed |
Hydroxyurea in Young Children With Sickle Cell Anemia
|
||||
| 9 |
Completed
Has Results |
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
|
||||
| 10 | Recruiting |
Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia
|
||||
| 11 | Recruiting |
Cardiovascular Complications of Sickle Cell Disease
|
||||
| 12 | Completed |
Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
|
||||
| 13 | Recruiting |
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
|
||||
| 14 | Recruiting |
A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease
|
||||
| 15 | Completed |
Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)
|
||||
| 16 | Active, not recruiting |
Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease
|
||||
| 17 | Recruiting |
Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
|
||||
| 18 | Recruiting |
Use of a Mobile-based App for SCD Patients
|
||||
| 19 | Completed |
Deferoxamine for the Treatment of Hemochromatosis
|
||||
| 20 | Completed |
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
|
† Indicates status has not been verified in more than two years
